A Comparison between Maternal Serum Free β-Human Chorionic Gonadotrophin and Pregnancy-Associated Plasma Protein A Levels in First-Trimester Twin and Singleton Pregnancies
- 13 February 2004
- journal article
- research article
- Published by S. Karger AG in Fetal Diagnosis and Therapy
- Vol. 19 (2) , 174-177
- https://doi.org/10.1159/000075145
Abstract
Objectives: To determine the levels of first-trimester free β-human chorionic gonadotrophin (free βhCG), pregnancy-associated plasma protein A (PAPP-A) and nuchal translucency (NT) in twin pregnancies. Methods: The study included 93 patients with twin pregnancy and 4,977 with singletons who underwent first-trimester testing using free βhCG, PAPP-A and NT at 10–13 weeks of gestational age. Results: In twin pregnancies, the maternal serum free βhCG level was 2.18 higher and the PAPP-A level was 2.38 higher than in singleton pregnancies. These marker levels were significantly higher than the expected 2.0 multiples of the median (MoM). In contrast, NT values did not differ between twins and singletons. Conclusion: These data may be used to establish first-trimester combined screening for twin pregnancies.Keywords
This publication has 6 references indexed in Scilit:
- Maternal serum human chorionic gonadotrophin and pregnancy-associated plasma protein A in twin pregnancies in the first trimesterPrenatal Diagnosis, 2002
- Screening for trisomy 21 in twin pregnancies in the first trimester using free ?-hCG and PAPP-A, combined with fetal nuchal translucency thicknessPrenatal Diagnosis, 2000
- Annual Summary of Vital Statistics—1997Pediatrics, 1998
- Differential increases in AFP, hCG, and uE3 in twin pregnancies: Impact on attempts to quantify Down syndrome screening calculationsAmerican Journal of Medical Genetics, 1997
- Maternal Serum Screening for Fetal Down Syndrome: Clinical AspectsClinical Obstetrics and Gynecology, 1996
- MULTIPLE MARKER SCREENING FOR DOWN SYNDROME IN TWIN PREGNANCIESPrenatal Diagnosis, 1996